FC

Farallon Capital Management LLC

Diversified strategyHigh-turnover traderContrarian

Total reported value

$17.5B

Reporting period: 2026-03-31 · Number of holdings: 172

FARALLON CAPITAL MANAGEMENT LLC disclosed 172 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $17.5B and a quarterly turnover rate of 200.0%.

Personality snowflake

Concentration
14.37
Portfolio Stability
100
Momentum/Contrarian
0
Sector conviction
91.59
Diversification
100
Sizing Uniformity
77.18

Recent moves

  • New buy 78462F953

  • New buy RVMD

  • New buy AMZN

  • New buy MSFT

  • New buy AON

  • New buy BBIO

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1✓ Spdr S&p 500 ETF TrETF-Large Cap & Growth8.53%+8.53%NEW
2RVMDRevolution Medicines INCStock-Healthcare7.54%+7.54%NEW
3AMZNAmazon.com INCStock-Consumer Disc5.01%+5.01%NEW
4MSFTMicrosoft CORPStock-Tech4.95%+4.95%NEW
5AONAon plcStock-Financials4.62%+4.62%NEW
6BBIOBridgebio Pharma INCStock-Healthcare3.96%+3.96%NEW
7✓ Invesco Exchange Traded Fd TStock-Other3.94%+3.94%NEW
8PTGXProtagonist Therapeutics INCStock-Other3.81%+3.81%NEW
9NTRANatera INCStock-Healthcare3.66%+3.66%NEW
10EXELExelixis INCStock-Healthcare3.21%+3.21%NEW
11AVGOBroadcom INCStock-Tech3.14%+3.14%NEW
12UNHUnitedhealth Group INCStock-Healthcare2.81%+2.81%NEW
13SNPSSynopsys INCStock-Tech2.74%+2.74%NEW
14BSXBoston Scientific CORPStock-Healthcare2.67%+2.67%NEW
15TMOThermo Fisher Scientific INCStock-Healthcare2.47%+2.47%NEW
16KKRKkr & Co INCStock-Financials2.46%+2.46%NEW
17LNTHLantheus Holdings INCStock-Healthcare2.41%+2.41%NEW
18WABWabtec CORPStock-Industrials2.29%+2.29%NEW
19SCHWSchwab (charles) CORPStock-Financials2.12%+2.12%NEW
20LQDALiquidia CORPStock-Other1.86%+1.86%NEW
21CRNXCrinetics Pharmaceuticals InStock-Other1.73%+1.73%NEW
22GOOGAlphabet Inc-cl CStock-Comm Services1.63%+1.63%NEW
23ROIVRoivant Sciences Ltd.Stock-Healthcare1.53%+1.53%NEW
24VVisa Inc-class A SharesStock-Financials1.45%+1.45%NEW
25ARMKAramarkStock-Industrials1.42%+1.42%NEW
26BEAMBeam Therapeutics INCStock-Other1.38%+1.38%NEW
27DISWalt Disney Co/theStock-Comm Services1.32%+1.32%NEW
28MAMastercard INC - AStock-Financials1.24%+1.24%NEW
29MCKMckesson CORPStock-Healthcare1.16%+1.16%NEW
30AGIOAgios Pharmaceuticals INCStock-Other1.10%+1.10%NEW
31260Centessa Pharmaceuticals-adrStock-Other1.09%+1.09%NEW
32TNGXTango Therapeutics INCStock-Other1.08%+1.08%NEW
33GRALGrail INCStock-Healthcare0.96%+0.96%NEW
34TYRATyra Biosciences INCStock-Other0.78%+0.78%NEW
35THCTenet Healthcare CORPStock-Healthcare0.49%+0.49%NEW
36CAHCardinal Health INCStock-Healthcare0.44%+0.44%NEW
37PCVXVaxcyte INCStock-Other0.42%+0.42%NEW
38DNTHDianthus Therapeutics INCStock-Other0.40%+0.40%NEW
39BTSGBrightspring Health ServicesStock-Other0.39%+0.39%NEW
40TWSTTwist Bioscience CORPStock-Other0.39%+0.39%NEW
41BIDUBaidu INC - Spon AdrStock-Comm Services0.28%+0.28%NEW
42CGONCg Oncology INCStock-Other0.26%+0.26%NEW
43AZNAstraZeneca PLCStock-Healthcare0.25%+0.25%NEW
44VNET 2 10-01-27Vnet Group INCStock-Other0.25%+0.25%NEW
45MRKMerck & Co. INC.Stock-Healthcare0.25%+0.25%NEW
46ACHCAcadia Healthcare Co INCStock-Other0.23%+0.23%NEW
47WELLWelltower INCStock-Real Estate0.23%+0.23%NEW
48IMVTImmunovant INCStock-Other0.22%+0.22%NEW
49ENTAEnanta Pharmaceuticals INCStock-Other0.21%—+3.59%
50JNJJohnson & JohnsonStock-Healthcare0.21%——
1–50 of 172

Holding changes this quarter

Farallon Capital Management LLC's most significant position changes for 2026-03-31: New buy: Spdr S&p 500 ETF Tr; New buy: Revolution Medicines INC (RVMD); New buy: Amazon.com INC (AMZN); New buy: Microsoft CORP (MSFT); New buy: Aon plc (AON).

Position changes disclosed by Farallon Capital Management LLC for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1✓ Spdr S&p 500 ETF Tr—NEWNew buy
2RVMDRevolution Medicines INC—NEWNew buy
3AMZNAmazon.com INC—NEWNew buy
4MSFTMicrosoft CORP—NEWNew buy
5AONAon plc—NEWNew buy
6BBIOBridgebio Pharma INC—NEWNew buy
7✓ Invesco Exchange Traded Fd T—NEWNew buy
8PTGXProtagonist Therapeutics INC—NEWNew buy
9EXKExact Sciences CORP—EXITSold out
10NTRANatera INC—NEWNew buy
11EXELExelixis INC—NEWNew buy
12AVGOBroadcom INC—NEWNew buy
13UNHUnitedhealth Group INC—NEWNew buy
14SNPSSynopsys INC—NEWNew buy
15BSXBoston Scientific CORP—NEWNew buy
16TMOThermo Fisher Scientific INC—NEWNew buy
17KKRKkr & Co INC—NEWNew buy
18LNTHLantheus Holdings INC—NEWNew buy
19WABWabtec CORP—NEWNew buy
20SCHWSchwab (charles) CORP—NEWNew buy
21LQDALiquidia CORP—NEWNew buy
22CRNXCrinetics Pharmaceuticals In—NEWNew buy
23GOOGAlphabet Inc-cl C—NEWNew buy
24ROIVRoivant Sciences Ltd.—NEWNew buy
25VVisa Inc-class A Shares—NEWNew buy
26ARMKAramark—NEWNew buy
27BEAMBeam Therapeutics INC—NEWNew buy
28RNAGBPAvidity Biosciences INC—EXITSold out
29DISWalt Disney Co/the—NEWNew buy
30MAMastercard INC - A—NEWNew buy
31MCKMckesson CORP—NEWNew buy
32AGIOAgios Pharmaceuticals INC—NEWNew buy
33260Centessa Pharmaceuticals-adr—NEWNew buy
34TNGXTango Therapeutics INC—NEWNew buy
35GRALGrail INC—NEWNew buy
36TYRATyra Biosciences INC—NEWNew buy
37THCTenet Healthcare CORP—NEWNew buy
38CAHCardinal Health INC—NEWNew buy
39PCVXVaxcyte INC—NEWNew buy
40DNTHDianthus Therapeutics INC—NEWNew buy
41BTSGBrightspring Health Services—NEWNew buy
42TWSTTwist Bioscience CORP—NEWNew buy
43BIDUBaidu INC - Spon Adr—NEWNew buy
44CGONCg Oncology INC—NEWNew buy
45AZNAstraZeneca PLC—NEWNew buy
46VNET 2 10-01-27Vnet Group INC—NEWNew buy
47MRKMerck & Co. INC.—NEWNew buy
48ACHCAcadia Healthcare Co INC—NEWNew buy
49WELLWelltower INC—NEWNew buy
50IMVTImmunovant INC—NEWNew buy

FAQ

What is Farallon Capital Management LLC and what type of investor is it?
Farallon Capital Management LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $17.5B, spread across 172 disclosed positions.
What are Farallon Capital Management LLC's largest equity positions?
Based on the latest 13F filing, Farallon Capital Management LLC's top holdings by market value are: 1. Spdr S&p 500 ETF Tr — $1.5B (8.5%) 2. Revolution Medicines INC (RVMD) — $1.3B (7.5%) 3. Amazon.com INC (AMZN) — $878.6M (5.0%) 4. Microsoft CORP (MSFT) — $868.0M (5.0%) 5. Aon plc (AON) — $811.0M (4.6%)
What changes did Farallon Capital Management LLC make in its most recent portfolio filing?
In the latest reported quarter, Farallon Capital Management LLC made 50 notable position adjustments: 48 new positions were initiated, 0 existing holdings were added to, 0 positions were partially reduced, and 2 were completely exited. The largest of these moves: New buy: Spdr S&p 500 ETF Tr; New buy: Revolution Medicines INC (RVMD); New buy: Amazon.com INC (AMZN); New buy: Microsoft CORP (MSFT); New buy: Aon plc (AON)
What sectors does Farallon Capital Management LLC focus on?
Farallon Capital Management LLC is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 49.0% • Financials: 17.1% • Information Technology: 15.9% • Consumer Discretionary: 7.2% • Industrials: 5.5% • Communication Services: 4.9%